Antioxidative enzyme activity and total antioxidant capacity in serum of dogs with degenerative mitral valve disease
- PMID: 31949330
- PMCID: PMC6923815
Antioxidative enzyme activity and total antioxidant capacity in serum of dogs with degenerative mitral valve disease
Abstract
This study was designed to evaluate the antioxidative status of serum by measuring its total antioxidant capacity, as well as the antioxidant enzyme activity (superoxide dismutase, catalase, and glutathione reductase), in dogs with various stages of degenerative mitral valve disease (DMVD) compared to healthy controls. In total, 71 client-owned dogs in different stages of DMVD, which included healthy controls, took part in the study. Following an anamnesis, clinical examination, standard transthoracic echocardiograpic examination, chest X-ray, complete blood (cell) count, and serum biochemistry, dogs were divided into 2 study groups. Blood was drawn from each dog once at the time of presentation and selected antioxidant parameters were measured using commercially available assay kits. The activity of superoxide dismutase gradually decreased in the more advanced stages of DMVD, while the activity of catalase was significantly higher in the group of dogs with asymptomatic DMVD compared to healthy controls and dogs with symptomatic DMVD. No significant changes were noted in total antioxidant capacity and the activity of glutathione reductase. Results suggested that DMVD has a significant impact on the activity of superoxide dismutase and catalase in the serum of the tested dogs. Knowledge of changes in the activity of antioxidative enzymes may warrant further studies, possibly to evaluate the potential role of compounds with antioxidative properties in the clinical outcome of dogs with DMVD.
La présente étude a été conçue afin d’évaluer le statut antioxydant du sérum en mesurant sa capacité antioxydante totale, ainsi que l’activité antioxydante enzymatique (superoxyde dismutase, catalase, et glutathion réductase), chez des chiens avec des degrés divers de maladie dégénérative de la valvule mitrale (DMVD) comparativement à des témoins en santé. Au total, 71 chiens appartenant à des clients à différents stades de DMVD, qui incluaient des témoins en santé, ont pris part à cette étude. À la suite de la prise d’anamnèse, d’un examen clinique, d’un examen échocardiographie transthoracique standard, de radiographie thoracique, d’un comptage cellulaire sanguin complet, et d’analyse biochimique sérique, les chiens étaient séparés en deux groupes d’étude. Du sang fut prélevé de chaque chien une fois au moment de la présentation et les paramètres antioxydants sélectionnés furent mesurés à l’aide d’une trousse disponible commercialement. L’activité de la superoxyde dismutase diminuait graduellement dans les stades plus avancés de DMVD, alors que l’activité de la catalase était significativement plus élevée dans le groupe de chiens avec une DMVD asymptomatique comparativement aux témoins en santé et aux chiens avec une DMVD symptomatique. Aucun changement significatif n’était noté dans la capacité antioxydante totale et dans l’activité de la glutathion réductase. Les résultats suggèrent que la DMVD a un impact significatif sur l’activité de la superoxyde dismutase, et de la catalase dans le sérum des chiens testés. Des connaissances sur les changements dans l’activité des enzymes antioxydantes pourraient justifier des études additionnelles, possiblement pour évaluer le rôle potentiel de produits avec des propriétés antioxydantes dans le devenir clinique de chiens avec DMVD.(Traduit par Docteur Serge Messier).
Copyright and/or publishing rights held by the Canadian Veterinary Medical Association.
Figures
Similar articles
-
A pilot study investigating circulating trimethylamine N-oxide and its precursors in dogs with degenerative mitral valve disease with or without congestive heart failure.J Vet Intern Med. 2019 Jan;33(1):46-53. doi: 10.1111/jvim.15347. Epub 2018 Dec 3. J Vet Intern Med. 2019. PMID: 30511765 Free PMC article.
-
Serum serotonin concentrations in dogs with degenerative mitral valve disease.J Vet Intern Med. 2009 Nov-Dec;23(6):1208-13. doi: 10.1111/j.1939-1676.2009.0378.x. Epub 2009 Aug 26. J Vet Intern Med. 2009. PMID: 19709352
-
Pulmonary Vein-to-Pulmonary Artery Ratio is an Echocardiographic Index of Congestive Heart Failure in Dogs with Degenerative Mitral Valve Disease.J Vet Intern Med. 2015 Nov-Dec;29(6):1502-9. doi: 10.1111/jvim.13634. Epub 2015 Sep 29. J Vet Intern Med. 2015. PMID: 26415640 Free PMC article.
-
New insights into degenerative mitral valve disease in dogs.Vet Clin North Am Small Anim Pract. 2004 Sep;34(5):1209-26, vii-viii. doi: 10.1016/j.cvsm.2004.05.002. Vet Clin North Am Small Anim Pract. 2004. PMID: 15325478 Review.
-
Canine degenerative myxomatous mitral valve disease: natural history, clinical presentation and therapy.Vet Clin North Am Small Anim Pract. 2010 Jul;40(4):651-63. doi: 10.1016/j.cvsm.2010.03.008. Vet Clin North Am Small Anim Pract. 2010. PMID: 20610017 Review.
Cited by
-
Effects of Coenzyme Q10 Supplementation on Oxidative Stress Markers, Inflammatory Markers, Lymphocyte Subpopulations, and Clinical Status in Dogs with Myxomatous Mitral Valve Disease.Antioxidants (Basel). 2022 Jul 22;11(8):1427. doi: 10.3390/antiox11081427. Antioxidants (Basel). 2022. PMID: 35892628 Free PMC article.
-
Evaluation of antioxidant status and lipid peroxidation in dogs with myxomatous mitral valve degeneration stage B1.Front Vet Sci. 2023 Sep 6;10:1203480. doi: 10.3389/fvets.2023.1203480. eCollection 2023. Front Vet Sci. 2023. PMID: 37745214 Free PMC article.
-
Effects of Blueberry Consumption on Preference, Digestibility, and Oxidative Balance in Dogs.Animals (Basel). 2025 May 21;15(10):1502. doi: 10.3390/ani15101502. Animals (Basel). 2025. PMID: 40427378 Free PMC article.
-
Differences in Levels of Mitochondrial DNA Content at Various Stages of Canine Myxomatous Mitral Valve Disease.Animals (Basel). 2023 Dec 14;13(24):3850. doi: 10.3390/ani13243850. Animals (Basel). 2023. PMID: 38136887 Free PMC article.
-
Changes of inflammatory and oxidative stress biomarkers in dogs with different stages of heart failure.BMC Vet Res. 2020 Nov 10;16(1):433. doi: 10.1186/s12917-020-02650-7. BMC Vet Res. 2020. PMID: 33167963 Free PMC article.
References
-
- Borgarelli M, Häggström J. Canine degenerative myxomatous mitral valve disease: Natural history, clinical presentation and therapy. Vet Clin North Am Small Anim Pract. 2010;40:651–663. - PubMed
-
- Häggström J, Hoglund K, Borgarelli M. An update on treatment and prognostic indicators in canine myxomatous mitral valve disease. J Small Anim Pract. 2009;50:25–33. - PubMed
-
- Whitney JC. Observations on the effect of age on the severity of heart valve lesions in the dog. J Small Anim Pract. 1974;15:511–522. - PubMed
-
- Borgarelli M, Zini E, D’Agnolo G, et al. Comparison of primary mitral valve disease in German Shepherd dogs and in small breeds. J Vet Cardiol. 2004;6:27–34. - PubMed
-
- Malik R, Hunt GB, Allan GS. Prevalence of mitral valve insufficiency in cavalier King Charles spaniels. Vet Rec. 1992;130:302–303. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical